IMPORTANT UPDATE October 2024:
Important Dates:
Objection & Opt-Out Deadline |
Passed (July 9, 2024) |
Settlement Approval Hearing |
October 1, 2024 |
Start of Claims Period |
November 1, 2024 |
Claim Deadline |
March 3, 2025 |
About the Class Action
On March 15, 2024, the BC Supreme Court certified the Class Action for the purpose of settlement. U-Dream is an over-the-counter sleep aid product that was manufactured and/or distributed by Biotrade Canada Ltd., London Drugs Limited, Rexall Pharmacy Group Ltd., Rexall/Pharma Plus Pharmacies Ltd., Whole Foods Market, Whole Foods Market Canada Inc. and PNP Pharmaceuticals Inc (the “Defendants”) in Canada.
The Plaintiff alleges that U-Dream was contaminated by an undisclosed ingredient and should never have been sold. Further, the Plaintiff alleges that it caused some Class Members to sustain injuries.
The settlement of the Class Action has been approved by the Court. The settlement is a compromise of disputed claims and is not an admission of liability or wrongdoing or fault by any of the Defendants.
Class Member Definition
The Class consists of: